Effects of anagrelide on platelet factor 4 and vascular endothelial growth factor levels in patients with essential thrombocythemia.
Cacciola
Rossella R
RR
Francesco
Ernesto Di
ED
Giustolisi
Rosario
R
Cacciola
Emma
E
D000328:Adult; D001792:Blood Platelets / Q000187:drug effects; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D010978:Platelet Factor 4 / Q000187:drug effects* / Q000378:metabolism; D011799:Quinazolines / Q000627:therapeutic use*; D013920:Thrombocythemia, Essential / Q000097:blood / Q000188:drug therapy*; D042461:Vascular Endothelial Growth Factor A / Q000097:blood / Q000187:drug effects*
D010975:Platelet Aggregation Inhibitors; D011799:Quinazolines; D042461:Vascular Endothelial Growth Factor A; D010978:Platelet Factor 4; C021139:anagrelide